Search Results for:
Research
Webinar: International Harm Reduction
In this webinar we explore how Australia can better uphold the health and human rights of people who use drugs both at home and globally.
Jude Byrne Award Recipients Lead Inspiring Narcofeminism Webinar with AIVL
This article was originally published on inhsu.org.au Applications are now open for the 2025 Jude Byrne Emerging Female Leader Award, and we were proud to see so many past recipients front and centre at a powerful recent webinar hosted by the Australian Injecting and Illicit Drug Users League (AIVL), focused on the global narcofeminist movement. The […]
Shop
Drug Policy and the Federal Election: Where the Parties Stand
The federal election is this Saturday, Saturday 3 May 2025. Here’s where the parties stand on some major drug policy issues. AIVL asked registered parties for the upcoming Federal Election a series of questions about key issues identified by our community. Not all parties responded or answered every question, so in some cases, we supplemented […]
Employment Opportunities
Physicians Call for Health-First Approach to Drug Policy in New Position Statement
The Royal Australasian College of Physicians (RACP) has published a position statement that focuses on the need for an evidence-based, comprehensive approach to drug policy that includes education, harm prevention and reduction, and treatment.
Home Testing Kits
Open to access this content
Which PrEP Medication Is Best For Me?
Open to access this content
Interactions With Hormone Therapy and Performance and Image Enhancing Drugs (PIEDs)
Open to access this content
Interactions With Drugs Used In Chemsex
Open to access this content
Topic
Open to access this content
Managing HIV & Treatments For Medicare Excluded Communities
Open to access this content
Topic
Open to access this content
Lesson
Open to access this content
Receiving a New Diagnosis
Open to access this content
Internalised Stigma & Stigma In Other Manifestations
Open to access this content
HIV & Other STIs
Open to access this content
Complying to treatments
Open to access this content
Webinar: Women & Nonbinary People Who Use Drugs Should Be Included in Feminism
In this webinar we reflect on the historical exclusion of women who use drugs from traditional feminist spaces and advocacy.
Experience Matters: Emerging Drugs and Trends
Experience Matters: Drug User Organisations
Experience Matters: Ethical Collaboration
Reporting on Harm Reduction & People Who Use Drugs
Experience Matters Episode #1 Emerging Drugs and Trends
Nitazenes, a synthetic opioid that can be up to 50 times stronger than fentanyl, is increasingly being found in unexpected substances like cocaine, methamphetamine, and MDMA across Australia. In this episode, we explore how drug policy, particularly prohibition, shapes emerging drug trends and how we respond to them to reduce harm.
HIV and what it does
Open to access this content
What is your immune system
Open to access this content
Leading the Way: A Peer-Led National Research Strategy for People Who Use Drugs
The start of 2025 has been an exciting time for AIVL’s National Research Program. At the heart of these developments is the establishment of the AIVL National Research Strategy Working Group, a critical step toward the creation of Australia’s first National Research Strategy for People Who Use Drugs, by People Who Use Drugs. No such […]
Human Rights and Drug Policy: Summary Report of Project Findings and Recommendations
A recent four-year national research project by La Trobe University has made significant recommendations to reshape Australia’s drug policies. The project advocates for the legalisation of certain drugs and calls for increased funding and support for organisations led by people who use drugs.
Webinar: People Who Use Drugs Make Excellent Parents
In this webinar, our speakers challenged harmful discrimination, broke down the evidence, and explored the real stories behind the stigma.
Liver Biopsy
Open to access this content
Topic
Open to access this content
The Liver
Open to access this content
Celebrating Excellence: Inaugural AIVL Network Awards Recipients 2024
Congratulations to the inaugural AIVL Network Awards recipients! These awards marked an emotional and unforgettable moment as we recognised and celebrated the remarkable contributions of these outstanding individuals and programs within our community.
The Australian Injecting and Illicit Drug User League (AIVL) Network Awards
The awards are an opportunity to celebrate the talent of our peer workforce and their vital contributions to advancing harm reduction practices and principles.
Celebrate International Drug Users Day 2024: Resources and Reflections
November 1 marks International Drug Users Day (IDUD)—a day for community, connection and celebration for people who use drugs worldwide—challenging the stigma and discrimination that erodes our access to healthcare, safety, self-determination and freedom. This year we want to reaffirm that the war on drugs is a war on people who use drugs. Despite widespread […]
Understanding and Responding to People Who Use Performance and Image Enhancing Drugs
An increasing number of individuals who use steroids and other performance and image enhancing drugs (PIEDS) are accessing Needle and Syringe Programs for injecting equipment. Watch this online training webinar to learn more about PIEDs and how to effectively support those who use them.
Webinar: Understanding and Responding to People Who Use Performance and Image Enhancing Drugs
Performance and Image Enhancing Drugs (PIEDs) are the fastest growing drug category reflected in NSP statistics across Australia.
Join Us at the Health and Human Rights Summit: Advancing the Wellbeing of People Who Use Drugs
A full-day event designed to bring together community members, advocates, individuals, and organisations.
Health and Human Rights Summit – Advancing the Wellbeing of People Who Use Drugs
This three-day event brought together AIVL Member Organisations, Affiliate Members, partners, and allies to engage in presentations, workshops, and panel discussions focused on the health and human rights of people who use drugs.
Introducing PACE: A Creative Movement for Artists Who Use Drugs
Are you a person who uses drugs? Do you express your creativity through painting, photography, installations, street art, poems, or songs? If so, PACE (Peer Arts Collective Exhibition) invites you to be part of a project that celebrates creativity, connection, and the power of expression.
Overdose Awareness Day
For Overdose Awareness Day 2024, we explore the barriers and successes in naloxone provision, with insights from Australia and Portugal’s community distribution efforts.
World Hepatitis Day
AIVL hosted a webinar to discuss how we can carry forward the lessons learned from our past to protect the health and freedom of our diverse community in the future.
Terms of Use
No one likes using the dirties – A study into the re-use of injecting equipment in Australia
Hepatitis C and Prison: The Key Issues
A needs analysis for people living with HCV after leaving custodial settings in Australia
Our History
A Hidden Population: Healthy Ageing
Development of a National Peer Work Framework
Working to develop a comprehensive framework and guide for the employment of people who use drugs in harm reduction peer positions.
online Course Registration
Support. Don’t Punish
AIVL hosted an online forum to discuss and platform some of the local and international services, systems, advocacy and policies that are working to advance the health, wellbeing and human rights of people who use drugs.
The Being Real Project: Drug User Organisations working with Aboriginal people who use drugs and Aboriginal Community Controlled Organisations
Ethical issues for research involving injecting/illicit drug users
Campaigns
Lesson
Open to access this content
Support Don’t Punish
Eliminate violence against women and gender diverse people who use drugs
Highlighting the need to end violence against women and gender diverse people who use drugs and improve drug policies from a feminist, human rights and harm reduction perspective.
Spotlight on Overdose
Drug-related overdose impacts everyone. Each year, around 2000 people die of overdose in Australia. That means, a person dies of a drug-related overdose almost every 4 hours, while many more experience non-fatal overdose.
Topic
Open to access this content
Topic
Open to access this content
Topic
Open to access this content
Topic
Open to access this content
Victoria scraps proposed second injecting room
Diane Lloyd is a fierce advocate for her community. Loudly and fearlessly sharing her experiences and working tirelessly for the rights of people living with HIV, specifically for people who inject drugs, as an advocate and mentor.
Advocacy
We platform the voice of our community to advance the wellbeing, health and human rights of people who use drugs illicitly in Australia.
A Normal Day
This course focuses on creating better communication and clinical interactions between people who use drugs and medical professionals, breaking down some of the stigma, discrimination, and other barriers preventing equitable access to services for people who use drugs, along with challenging common misconceptions around people who use drugs and drug use.
*Some of the language and terminology used in this course, whilst standing as a true transcript of the audio files, is outdated and not reflective of present best practice language guides. We encourage you to use the resource ‘Language matters’ which can be downloaded in the resource section.*
A conversation with Diane Lloyd for World Aids Day
Diane Lloyd is a fierce advocate for her community. Loudly and fearlessly sharing her experiences and working tirelessly for the rights of people living with HIV, specifically for people who inject drugs, as an advocate and mentor.
Women who use drugs are particularly demonised and judged
Ele, our Director of Advocacy, was invited to speak on a panel for International Women’s Day. She was asked the following question
Checkout
Cart
My account
Steve Owen
Steve Owen
Steve Owen
Steve Owen
Vein Care Guide
Afternoons with Max Marshall: Short Film
Posters: co-designed with Mob who use NSPs
Peer Workforce Capacity Building Training Framework
Report: “Why wouldn’t I discriminate against all of them?”
Information For People On Opioid Treatment: Methadone, Suboxone, Subutex, & Buprenorphine Injections
Type Administration method Dosing frequency Brand names Methadone Liquid – Taken as a drink Daily Methadone Syrup® Biodone Forte Solution® Buprenorphine Sublingual – A tablet that dissolves under the tongue Once every 1 to 3 days Subutex® Buprenorphine-naloxone Sublingual – A film that dissolves under the tongue Once every 1 to 3 days Suboxone® Long-acting injectable […]
Injecting Involves Blood – Be ‘Blood Aware’
Needle and Syringe Programs In Australia: Peer-led Best Practice (The Guide)
National Peer Summit
The National Peer Summit brought together The AIVL Network from across Australia. Providing a space for meaningful dialogue, idea exchange, and strategising for a bright future led by people who use drugs.
The Australian State of Harm Reduction
On International Harm Reduction Day AIVL hosted an online forum to talk about ‘Harm Reduction’ in Australia.
International Drug Users Day
For our International Drug Users Day Celebration we invited members of The AIVL Network and guests from our community to have dinner in a relaxed, safe and celebratory space.
Changes To The Opioid Dependence Treatment Program: Consumers Forum
This online forum was for people on or interested in Opioid Dependence Treatment in Australia.
Stigma Conference
The inaugural Australian Stigma Conference was held on the 17th of November 2022, in the Great Hall at the Australian Parliament House. The forum-style conference brought together policymakers, healthcare professionals and people who use drugs to engage in dialogue and hear about how stigma impacts people who use drugs.
Changes To The Opioid Dependence Treatment Program: Implications for Access and Transitional Arrangements
This online forum was for people working within Opioid Dependence Treatment in Australia.
Events
AIVL hosts a variety of online and in-person events.
Plans & reports
Member Login
Membership Profile
Password Reset
NSP Directory
Canberra Alliance for Harm Minimisation and Advocacy (CAHMA)
Harm Reduction Victoria
SA Harm Reduction Peer Services (SAhrps)
Northern Territory AIDS and Hepatitis Council Inc (NTAHC)
NSW Users and AIDS Association (NUAA)
Peer Based Harm Reduction WA
QuIVAA
QuIHN
Tasmanian Users and Health Support League (TUHSL)
Member Organisations
Donate to aivl
AIVL Resources
AIVL has a variety of resources on harm reduction, hepatitis C, the impact of stigma and discrimination and more
Online Courses
Chris Gough
About AIVL
Staff & Board Members
CAHMA & The Connection: Working with women who use drugs & are involved with Child Protection
AIVL recently yarned with Monica Ruffy about her work through CAHMA and The Connection with a peer-based support group for mothers who use drugs, based in Canberra: The Jude Byrne Women’s Group, A group for women with AOD and Care and Protection involvement.
Campaign to eliminate violence against women and gender diverse people who use drugs
Women and gender diverse people who use drugs are subject to extreme levels and a wide range of violence due to patriarchal norms combined with punitive prohibition of some drugs.
What are nitazenes and why are they being found in heroin and ketamine in Australia?
If you’ve been keeping yourself up to date with drug alerts coming out of Canberra’s CanTEST facility then you’ve most likely seen recent drug alerts about the detection of novel synthetic opioid Metonitazene and more generally, Nitazenes.
Interview with DJ Bardi Girl from Deadly Human Rights show, Koori Radio
A yarn with DJ Bardi Girl, host of Koori Radios Deadly Human Rights Show.
Privacy Policy
AIVL News
Contact
HOME
Diet & Nutrition
Open to access this content
Experience Matters Episode #2 Drug User Organisations
Many people living in Australia don’t know what a Drug User Organisation is. In this episode, we have brought together the voices of harm reductionists, advocates, researchers, and our community to share why they think Drug User Organisations are important and what can be done to provide more support for them to continue their work into the future.
Where is the Liver?
Open to access this content
HIV & What It Does
Open to access this content
Ageing with care, autonomy and dignity
Open to access this content
1. Ageing with care, autonomy and dignity
Open to access this content
National & Online
Open to access this content
Introduction- What is Hepatitis?
Open to access this content
Introduction
Open to access this content
Introduction
Open to access this content
Introduction
Open to access this content
Introduction
Open to access this content
Introduction
Open to access this content
Introduction
Open to access this content
Introduction
Open to access this content
Introduction
Open to access this content
Introduction
Open to access this content
Introduction
Open to access this content
Introduction
Open to access this content
Introduction
Open to access this content
Introduction
Open to access this content
Leah McLeod
Experience Matters Episode #3 Ethical Collaboration
People who use drugs and Drug User Organisations have been fighting for ethical collaboration throughout our history, to be genuinely respected as people with expertise and allowed to lead the responses that affect our community. In this episode, we learn about ethical collaboration from the community in a range of settings and with different partners.
What Does the Liver do?
Open to access this content
HIV & AIDS
Open to access this content
Understanding older drug users
Open to access this content
New South Wales
Open to access this content
Hepatitis C Pathways: A Harm Reduction Guide for Community Wellness
This short course covers information about living with hepatitis C, preventing hepatitis C transmission, testing and treatment.
Sione Crawford
Stigma & Discrimination
Open to access this content
Effects of Hepatitis on the Liver
Open to access this content
A Place Of Their Own
This training aims to raise awareness of ageing people who use drugs and their particular needs, so we can equip our aged care workforce and facilities with better skills, knowledge and support to care for older people who use drugs.
Why not ‘simply stop?’
Open to access this content
South Australia
Open to access this content
Episode #1 – In conversation with Esha Leydon from QuIHN
We speak with peer harm reduction worker Esha Leydon about vein advice and hepatitis C treatment and get some insights about her work at the NSP.
Jane Dicka
Nonfunctioning Liver
Open to access this content
HIV Transmission
Open to access this content
A workforce who need support and training
Open to access this content
International & Online
Open to access this content
Episode #2 – Jude Byrne in conversation with Geoff Ward from CAHMA
Geoff tells us about the services CAHMA provides to the community, the CAHMA volunteer program and some of the important issues facing illicit drug users.
Esha Leyden
Co-Infection
Open to access this content
HIV & Sex
Open to access this content
How can we get started with awareness raising?
Open to access this content
National & Online
Open to access this content
Episode #3 – Part 1 – Jude Byrne at INSHU (International Network of Hepatitis in Substance Users)
A chat about INHSU’s peer community day, its involvement with the conference and the important issues that came out of it.
Podcast
John G
Liver Health
Open to access this content
Sexual Health Testing
Open to access this content
Pharmacotherapy and Pain treatment
Open to access this content
Australian Capital Territory
Open to access this content
Episode #3 – Part 2 – Lauren Bradley at INHSU (International Network of Hepatitis in Substance Users)
A candid chat about Canada, the INHSU conference, some messages regarding harm reduction in custodial settings and big impressions!
Ele M
Monkey Pox (Mpox) Vaccination
Open to access this content
Liver Health
Open to access this content
Hepatitis C treatment and Prevention & Ongoing drug use in aged care settings
Open to access this content
New South Wales
Open to access this content
Molly H
What is Liver Fibrosis?
Open to access this content
PrEP & PEP Navigation For People Who Use Drugs
Open to access this content
Innovative Models of Care
Open to access this content
Northern Territory
Open to access this content
Jess D
What is Liver Cirrhosis
Open to access this content
HIV & Illicit Drug Use
Open to access this content
A Place of their own
Open to access this content
Queensland
Open to access this content
Emily E
Hepatitis C and your Diet
Open to access this content
Safer Using & Being Blood Aware
Open to access this content
Honest Conversations
Open to access this content
Tasmania
Open to access this content
Adrian G
Does what I eat matter?
Open to access this content
HIV Antibodies Test (ELISA)
Open to access this content
Richard K
So what now?
Open to access this content
Victoria
Open to access this content
How Hepatitis C can affect your Diet
Open to access this content
Pre & Post Test Discussions
Open to access this content
Your Action Plan
Open to access this content
Western Australia
Open to access this content
Samuele T
Tips for healthy eating
Open to access this content
Home Testing Kits
Open to access this content
International & Online
Open to access this content
HIV Treatments
Open to access this content
National & Online
Open to access this content
Managing HIV & Treatments
Open to access this content
Australian Capital Territory
Open to access this content
Supporting PWUD With Contact Tracing
Open to access this content
What is Sustained Virological Response and Why is it good?
Open to access this content
New South Wales
Open to access this content
HIV & Disclosure
Open to access this content
Northern Territory
Open to access this content
Self Advocacy in the HIV Health Care Space
Open to access this content
Queensland
Open to access this content
HIV Stigma
Open to access this content
South Australia
Open to access this content
How does Hepatitis affect the liver?
Open to access this content
U=U and Injecting Drug Use
Open to access this content
Tasmania
Open to access this content
ART Therapy & Access to People Who Use Drugs
Open to access this content
Victoria
Open to access this content
HIV & Women
Open to access this content
2. A workforce who need support and training
Open to access this content
Western Australia
Open to access this content
Services Directory
Open to access this content
National & Online
Open to access this content
Module 1: WHat is Hepatitis C (HCV)
Open to access this content
South Australia
Open to access this content
Episode 1: Test dummy 101
Open to access this content
National & Online
Open to access this content
Episode 1: Just a sign
Open to access this content
Australian Capital Territory
Open to access this content
Episode 1: Just a sign
Open to access this content
New South Wales
Open to access this content
Module 1: Opioid Epidemic and History of Overdose Response
Open to access this content
Northern Territory
Open to access this content
Module 1: Opioid Epidemic and History of Overdose Response
Open to access this content
Queensland
Open to access this content
Module 1: Opioid Epidemic and History of Overdose Response
Open to access this content
South Australia
Open to access this content
Module 1: Opioid Epidemic and History of Overdose Response
Open to access this content
Tasmania
Open to access this content
Module 1: Opioid Epidemic and History of Overdose Response
Open to access this content
Victoria
Open to access this content
Module 1: Opioid Epidemic and History of Overdose Response
Open to access this content
Western Australia
Open to access this content
Module 1: Opioid Epidemic and History of Overdose Response
Open to access this content
National & Online
Open to access this content
Module 1: Opioid Epidemic and History of Overdose Response
Open to access this content
National & Online
Open to access this content
Module 1: Opioid Epidemic and History of Overdose Response
Open to access this content
New South Wales
Open to access this content
Module 1: Opioid Epidemic and History of Overdose Response
Open to access this content
International & Online
Open to access this content
Liver Health
Open to access this content
National & Online
Open to access this content
Symptoms
Open to access this content
National & Online
Open to access this content
South Australia
Open to access this content
3. Pharmacotherapy and Pain Treatment
Open to access this content
National & Online
Open to access this content
Queensland
Open to access this content
Module 2: Your rights and responsibilities with HCV
Open to access this content
South Australia
Open to access this content
Episode 2: At Typical day in the waiting room
Open to access this content
Victoria
Open to access this content
Episode 2: At ypical day in the waiting room
Open to access this content
Episode 2: A typical day in the waiting room
Open to access this content
Module 2: Opioids and Overdose
Open to access this content
Module 2: Opioids and Overdose
Open to access this content
Module 2: Opioids and Overdose
Open to access this content
Module 2: Opioids and Overdose
Open to access this content
Module 2: Opioids and Overdose
Open to access this content
Module 2: Opioids and Overdose
Open to access this content
Module 2: Opioids and Overdose
Open to access this content
Module 2: Opioids and Overdose
Open to access this content
Module 2: Opioids and Overdose
Open to access this content
Module 2: Opioids and Overdose
Open to access this content
Hepatitis Transmission for PWID
Open to access this content
4. Hepatitis C treatment and prevention
Open to access this content
Module 3: Test results
Open to access this content
Episode 3: Just your run of the mill small talk
Open to access this content
Episode 3: Just your run of the mill small talk
Open to access this content
Episode 3: Just your run of the mill small talk
Open to access this content
Module 3: Overdose Response and Naloxone Administration
Open to access this content
Module 3: Overdose Response and Naloxone Administration
Open to access this content
Module 3: Overdose Response and Naloxone Administration
Open to access this content
Module 3: Overdose Response and Naloxone Administration
Open to access this content
Module 3: Overdose Response and Naloxone Administration
Open to access this content
Module 3: Overdose Response and Naloxone Administration
Open to access this content
Module 3: Overdose Response and Naloxone Administration
Open to access this content
Module 3: Overdose Response and Naloxone Administration
Open to access this content
Module 3: Overdose Response and Naloxone Administration
Open to access this content
Module 3: Overdose Response and Naloxone Administration
Open to access this content
Monitoring Disease Progression (Acknowledging interferon)
Open to access this content
5. Access to clinical staff and funding
Open to access this content
Module 4: Disclosure and Discrimination
Open to access this content
Episode 4: The simple act of renewing a script
Open to access this content
Episode 4: The simple act of renewing a script
Open to access this content
Episode 4: The simple act of renewing a script
Open to access this content
Module 4: Implementing OEND Programs
Open to access this content
Module 4: Implementing OEND Programs
Open to access this content
Module 4: Implementing OEND Programs
Open to access this content
Module 4: Implementing OEND Programs
Open to access this content
Module 4: Implementing OEND Programs
Open to access this content
Module 4: Implementing OEND Programs
Open to access this content
Module 4: Implementing OEND Programs
Open to access this content
Module 4: Implementing OEND Programs
Open to access this content
Module 4: Implementing OEND Programs
Open to access this content
Module 4: Implementing OEND Programs
Open to access this content
Liver Regeneration
Open to access this content
What is liver fibrosis?
Open to access this content
6. A Place of Their Own
Open to access this content
Module 5: HCV Treatment
Open to access this content
Episode 5: An ordinary trip to the pharmacy
Open to access this content
Episode 5: An ordinary trip to the pharmacy
Open to access this content
Episode 5: An ordinary trip to the pharmacy
Open to access this content
Conclusion
Open to access this content
Conclusion
Open to access this content
Conclusion
Open to access this content
Conclusion
Open to access this content
Conclusion
Open to access this content
Conclusion
Open to access this content
Conclusion
Open to access this content
Conclusion
Open to access this content
Conclusion
Open to access this content
Conclusion
Open to access this content
Hepatitis C and Diet
Open to access this content
What is liver cirrhosis?
Open to access this content
RESOURCES
Open to access this content
Module 6: Living with HCV
Open to access this content
Resources
Open to access this content
Resources
Open to access this content
Resources
Open to access this content
Module 7: Vaccination (Hep A & Hep B)
Open to access this content
Liver Scans and testing
Open to access this content
Module 8: HIV/ HCV Co-Infection
Open to access this content
Impact of SVR on Hepatitis C and Liver
Open to access this content
Module 9: PrEP & PEP
Open to access this content
Hepatitis C and Opiate Constipation
Open to access this content
Module 10: What can PWUD & PWID Do to Prevent Hepatitis C and HIV?
Open to access this content
Stress and Liver function
Open to access this content
Helpful Services & Resources
Open to access this content
Mental Health and Hepatitis C
Open to access this content
Seeking Professional help and Medical Advice
Open to access this content
Support Services
Open to access this content
Life After Treatment
Open to access this content
Glossary of Terms
Open to access this content